Red blood cell phenotype fidelity following glycerol cryopreservation optimized for research purposes.

Published online

Journal Article

Intact red blood cells (RBCs) are required for phenotypic analyses. In order to allow separation (time and location) between subject encounter and sample analysis, we developed a research-specific RBC cryopreservation protocol and assessed its impact on data fidelity for key biochemical and physiological assays. RBCs drawn from healthy volunteers were aliquotted for immediate analysis or following glycerol-based cryopreservation, thawing, and deglycerolization. RBC phenotype was assessed by (1) scanning electron microscopy (SEM) imaging and standard morphometric RBC indices, (2) osmotic fragility, (3) deformability, (4) endothelial adhesion, (5) oxygen (O2) affinity, (6) ability to regulate hypoxic vasodilation, (7) nitric oxide (NO) content, (8) metabolomic phenotyping (at steady state, tracing with [1,2,3-13C3]glucose ± oxidative challenge with superoxide thermal source; SOTS-1), as well as in vivo quantification (following human to mouse RBC xenotransfusion) of (9) blood oxygenation content mapping and flow dynamics (velocity and adhesion). Our revised glycerolization protocol (40% v/v final) resulted in >98.5% RBC recovery following freezing (-80°C) and thawing (37°C), with no difference compared to the standard reported method (40% w/v final). Full deglycerolization (>99.9% glycerol removal) of 40% v/v final samples resulted in total cumulative lysis of ~8%, compared to ~12-15% with the standard method. The post cryopreservation/deglycerolization RBC phenotype was indistinguishable from that for fresh RBCs with regard to physical RBC parameters (morphology, volume, and density), osmotic fragility, deformability, endothelial adhesivity, O2 affinity, vasoregulation, metabolomics, and flow dynamics. These results indicate that RBC cryopreservation/deglycerolization in 40% v/v glycerol final does not significantly impact RBC phenotype (compared to fresh cells).

Full Text

Duke Authors

Cited Authors

  • Rogers, SC; Dosier, LB; McMahon, TJ; Zhu, H; Timm, D; Zhang, H; Herbert, J; Atallah, J; Palmer, GM; Cook, A; Ernst, M; Prakash, J; Terng, M; Towfighi, P; Doctor, R; Said, A; Joens, MS; Fitzpatrick, JAJ; Hanna, G; Lin, X; Reisz, JA; Nemkov, T; D'Alessandro, A; Doctor, A

Published Date

  • 2018

Published In

Volume / Issue

  • 13 / 12

Start / End Page

  • e0209201 -

PubMed ID

  • 30576340

Pubmed Central ID

  • 30576340

Electronic International Standard Serial Number (EISSN)

  • 1932-6203

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0209201

Language

  • eng

Conference Location

  • United States